Geneva, Aug. 29 -- International Clinical Trials Registry received information related to the study (NCT07133191) titled 'A Trial to Compare What the Body Does to Selatogrel and the Effect of Selatogrel in Japanese and Caucasian Healthy Participants' on Aug. 13.
Study Type: Interventional
Study Design:
Allocation: Randomized. Intervention model: Parallel Assignment. Primary purpose: Other. Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor).
Primary Sponsor: Viatris Innovation GmbH
Condition:
Healthy Volunteers
Intervention:
Combination Product: Selatogrel
Recruitment Status: Not recruiting
Phase: Phase 1
Date of First Enrollment: September 2025
Target Sample Size: 32
To know more, visit https...